Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | SVP Fin. - Global Controller | May 05, 2026 | May 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date May 05, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2029-05-05 | Direct | 2,298 |
Reported balance
After 2026-05-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-05 · Grant · Acquired 2,298 · Balance 2,298 F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $113.15 · Expires 2036-05-04 | Direct | 5,045 |
Reported balance
After 2026-05-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-05 · Grant · Acquired 5,045 · Balance 5,045 F3: The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. |
| Common StockSEC Table I · non-derivative | Direct | 9,388.315 |
Reported balance
Holding disclosure · report date 2026-05-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 9,388.315 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
F3: The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2026 Filed May 7, 2026 15:39 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (Right to Buy) · Derivative | 5,045 | $0.00 Strike: $113.15 | $0.00 |
DisclosureSEC source: 0000310158-26-000119 · form4.xml · derivative · entry 3 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,045 Underlying: Common Stock · 5,045 shares Expires 2036-05-04 F3 · derivative.exercise_date: The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. Read SEC document |
| May 05, 2026 Filed May 7, 2026 15:39 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 2,298 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-26-000119 · form4.xml · derivative · entry 2 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,298 Underlying: Common Stock · 2,298 shares Expires 2029-05-05 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029. Read SEC document |
| May 02, 2026 Filed May 5, 2026 17:51 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-26-000115 · form4.xml · derivative · entry 3 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 383 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025, and 5/2/2026. Read SEC document |
| May 02, 2026 Filed May 5, 2026 17:51 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 132 | $112.16 | $14,805.12 |
DisclosureSEC source: 0000310158-26-000115 · form4.xml · nonDerivative · entry 2 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,388.315 Read SEC document |
| May 02, 2026 Filed May 5, 2026 17:51 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 383 | $112.16 | $42,957.28 |
DisclosureSEC source: 0000310158-26-000115 · form4.xml · nonDerivative · entry 1 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,520.315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2026 Filed May 1, 2026 21:55 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 464 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-26-000090 · form4.xml · derivative · entry 6 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465 Underlying: Common Stock · 464 shares Expires 2027-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. Read SEC document |
| April 30, 2026 Filed May 1, 2026 21:55 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 159 | $110.95 | $17,641.05 |
DisclosureSEC source: 0000310158-26-000090 · form4.xml · nonDerivative · entry 4 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,137.315 Read SEC document |
| April 30, 2026 Filed May 1, 2026 21:55 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 464 | $110.95 | $51,480.80 |
DisclosureSEC source: 0000310158-26-000090 · form4.xml · nonDerivative · entry 3 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,296.315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2026 Filed May 1, 2026 21:55 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 944 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-26-000090 · form4.xml · derivative · entry 5 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,889 Underlying: Common Stock · 944 shares Expires 2028-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028. Read SEC document |
| April 29, 2026 Filed May 1, 2026 21:55 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 324 | $110.03 | $35,649.72 |
DisclosureSEC source: 0000310158-26-000090 · form4.xml · nonDerivative · entry 2 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,832.315 Read SEC document |
| April 29, 2026 Filed May 1, 2026 21:55 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 944 | $110.03 | $103,868.32 |
DisclosureSEC source: 0000310158-26-000090 · form4.xml · nonDerivative · entry 1 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,156.315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $62.07 | $0.00 |
DisclosureSEC source: 0000310158-26-000042 · form4.xml · derivative · entry 4 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,130 Underlying: Common Stock · 4,000 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 2,400 | $119.68 | $287,220.00 |
DisclosureSEC source: 0000310158-26-000042 · form4.xml · nonDerivative · entry 3 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,204.816 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 4,000 | $119.68 | $478,700.00 |
DisclosureSEC source: 0000310158-26-000042 · form4.xml · nonDerivative · entry 2 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,604.816 Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 4,000 | $62.07 | $248,280.00 |
DisclosureSEC source: 0000310158-26-000042 · form4.xml · nonDerivative · entry 1 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,604.816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 1,066 | $107.40 | $114,488.40 |
DisclosureSEC source: 0000310158-26-000024 · form4.xml · nonDerivative · entry 1 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,604.816 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/23. Performance shares were paid out at 94 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2025. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 03, 2025 Filed May 5, 2025 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 1,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013348 · form4.xml · derivative · entry 6 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,532 shares Expires 2025-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in equal, annual installments with one installment having vested on 5/3/2024 and the last installment having vested on 5/3/2025. Read SEC document |
| May 03, 2025 Filed May 5, 2025 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 518 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013348 · form4.xml · derivative · entry 5 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 518 shares Expires 2025-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in equal, annual installments with one installment having vested on 5/3/2024 and the last installment having vested on 5/3/2025. Read SEC document |
| May 03, 2025 Filed May 5, 2025 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 588 | $83.18 | $48,909.84 |
DisclosureSEC source: 0001127602-25-013348 · form4.xml · nonDerivative · entry 4 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,538.802 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 03, 2025 Filed May 5, 2025 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 1,532 | $83.18 | $127,431.76 |
DisclosureSEC source: 0001127602-25-013348 · form4.xml · nonDerivative · entry 3 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,126.802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2025 Filed May 5, 2025 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 256 | $83.18 | $21,294.08 |
DisclosureSEC source: 0001127602-25-013348 · form4.xml · nonDerivative · entry 2 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,594.802 Read SEC document |
| May 03, 2025 Filed May 5, 2025 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 518 | $83.18 | $43,087.24 |
DisclosureSEC source: 0001127602-25-013348 · form4.xml · nonDerivative · entry 1 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,850.802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2025 Filed May 2, 2025 20:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 381 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013190 · form4.xml · derivative · entry 6 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383 Underlying: Common Stock · 381 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026. Read SEC document |
| May 02, 2025 Filed May 2, 2025 20:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 131 | $83.26 | $10,907.06 |
DisclosureSEC source: 0001127602-25-013190 · form4.xml · nonDerivative · entry 4 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,332.802 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2025 Filed May 2, 2025 20:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 381 | $83.26 | $31,722.06 |
DisclosureSEC source: 0001127602-25-013190 · form4.xml · nonDerivative · entry 3 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,463.802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 464 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013190 · form4.xml · derivative · entry 5 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 929 Underlying: Common Stock · 464 shares Expires 2027-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 159 | $84.71 | $13,468.89 |
DisclosureSEC source: 0001127602-25-013190 · form4.xml · nonDerivative · entry 2 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,082.802 Read SEC document |
| April 30, 2025 Filed May 2, 2025 20:18 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 464 | $84.71 | $39,305.44 |
DisclosureSEC source: 0001127602-25-013190 · form4.xml · nonDerivative · entry 1 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,241.802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2025 Filed May 1, 2025 22:19 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (Right to Buy) · Derivative | 6,448 | $0.00 Strike: $84.71 | $0.00 |
DisclosureSEC source: 0001127602-25-013057 · form4.xml · derivative · entry 3 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,448 Underlying: Common Stock · 6,448 shares Expires 2035-04-28 F4 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028. Read SEC document |
| April 29, 2025 Filed May 1, 2025 22:19 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 2,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013057 · form4.xml · derivative · entry 2 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,833 Underlying: Common Stock · 2,833 shares Expires 2028-04-29 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 20:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.08 | $0.00 |
DisclosureSEC source: 0001127602-25-012727 · form4.xml · derivative · entry 3 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2025-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 20:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 4,262 | $82.76 | $352,723.12 |
DisclosureSEC source: 0001127602-25-012727 · form4.xml · nonDerivative · entry 2 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,777.802 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 20:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 5,000 | $58.08 | $290,400.00 |
DisclosureSEC source: 0001127602-25-012727 · form4.xml · nonDerivative · entry 1 Smart Dalton E. III · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,039.802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 23:25 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 2,586 | $97.94 | $253,272.84 |
DisclosureSEC source: 0001127602-25-002353 · form4.xml · nonDerivative · entry 1 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,014.286 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/22. Performance shares were paid out at 169 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2024. Read SEC document |
| May 04, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 612 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · derivative · entry 9 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 612 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock on 5/4/2024. Read SEC document |
| May 04, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 302 | $127.51 | $38,508.02 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · nonDerivative · entry 6 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,428.286 Read SEC document |
| May 04, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 612 | $127.51 | $78,036.12 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · nonDerivative · entry 5 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,730.286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · derivative · entry 8 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,532 Underlying: Common Stock · 1,530 shares Expires 2025-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in equal, annual installments with one installment having vested on 5/3/2024 and the last installment to vest on 5/3/2025. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 516 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · derivative · entry 7 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 518 Underlying: Common Stock · 516 shares Expires 2025-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in equal, annual installments with one installment having vested on 5/3/2024 and the last installment to vest on 5/3/2025. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 590 | $128.26 | $75,673.40 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · nonDerivative · entry 4 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,118.286 Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 1,530 | $128.26 | $196,237.80 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · nonDerivative · entry 3 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,708.286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 255 | $128.26 | $32,706.30 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · nonDerivative · entry 2 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,178.286 Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:10 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 516 | $128.26 | $66,182.16 |
DisclosureSEC source: 0001127602-24-014271 · form4.xml · nonDerivative · entry 1 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,433.286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 381 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013981 · form4.xml · derivative · entry 5 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 764 Underlying: Common Stock · 381 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 131 | $128.80 | $16,872.80 |
DisclosureSEC source: 0001127602-24-013981 · form4.xml · nonDerivative · entry 2 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,917.286 F1 · balance_after: Includes .041 shares of Merck & Co., Inc. common stock not previously reported due to a clerical error. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 381 | $128.80 | $49,072.80 |
DisclosureSEC source: 0001127602-24-013981 · form4.xml · nonDerivative · entry 1 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,048.286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (Right to Buy) · Derivative | 7,031 | $0.00 Strike: $129.22 | $0.00 |
DisclosureSEC source: 0001127602-24-013981 · form4.xml · derivative · entry 4 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,031 Underlying: Common Stock · 7,031 shares Expires 2034-04-29 F4 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 1,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013981 · form4.xml · derivative · entry 3 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,393 Underlying: Common Stock · 1,393 shares Expires 2027-04-30 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 21:16 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 2,661 | $119.43 | $317,803.23 |
DisclosureSEC source: 0001127602-24-002034 · form4.xml · nonDerivative · entry 1 Smart Dalton · CIK 0002003375 · SVP Fin. - Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,667.245 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.